Coegin Pharma AB (NGM:COEGIN)

Sweden flag Sweden · Delayed Price · Currency is SEK
5.06
-0.02 (-0.39%)
At close: Dec 3, 2025
32.81%
Market Cap 121.90M
Revenue (ttm) n/a
Net Income (ttm) -20.64M
Shares Out 24.88M
EPS (ttm) -0.80
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 7,033
Average Volume 28,187
Open n/a
Previous Close 5.08
Day's Range n/a
52-Week Range 2.89 - 9.52
Beta 1.27
RSI 33.62
Earnings Date Nov 20, 2025

About Coegin Pharma AB

Coegin Pharma AB, a biotechnology company, engages in developing peptide-based products for hair growth and skin pigmentation in Sweden. The company develops Follicopeptide, a peptide designed to enhance hair growth; and NPP-4, a natural pigmentation peptide 4 works by facilitating the transport of melanin to the skin, mimicking the natural process that occurs during sun exposure or tanning beds. It is also developing FOL026, a drug candidate which is in preclinical trial for the treatment of myocardial infarction; AVX420, a drug candidate whic... [Read more]

Industry Pharmaceutical Preparations
Founded 2005
Employees 1
Stock Exchange Nordic Growth Market
Ticker Symbol COEGIN
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.